Over the forecast period of 2022-2028, the Global Natural Killer (NK) Cell Therapeutics market is expected to grow at a CAGR of 51.8%. Pharmaceutical companies are becoming increasingly interested in cellular immunotherapy. Due to their ability to fulfill unmet medical needs, overcome the limitations associated with existing immunotherapies, and address complex and challenging targets, NK cell therapeutics are expected to witness robust growth during the forecast period.